Literature DB >> 25284578

A family history of diabetes determines poorer glycaemic control and younger age of diabetes onset in immigrants from the Middle East compared with native Swedes.

L Bennet1, U Lindblad2, P W Franks3.   

Abstract

AIMS: Immigrant populations from the Middle East develop diabetes earlier than indigenous European populations; however, the underlying etiology is poorly understood. This study looked at the risk factors associated with early diabetes onset and, in non-diabetics, glycaemic control in immigrants from Iraq compared with native Swedes.
METHODS: This cross-sectional population-based study comprised 1398 Iraqi immigrants and 757 Swedes (ages 30-75years) residing in the same area of Malmö, Sweden. Outcomes were age at diabetes onset and glycaemic control (HbA1c) as assessed by Cox proportional hazards and linear regression, respectively.
RESULTS: In Iraqis vs Swedes, clustering in the family history (in two or more relatives) was more prevalent (23.2% vs 3.6%, P<0.001) and diabetes onset occurred earlier (47.6years vs 53.4years, P=0.001). Having an Iraqi background independently raised the hazard ratio (HR) for diabetes onset. Diabetes risk due to family history was augmented by obesity, with the highest HRs observed in obese participants with clustering in the family history (HR: 5.1, 95% CI: 3.2-8.2) after adjusting for country of birth and gender. In participants without previously diagnosed diabetes (Iraqis: n=1270; Swedes: n=728), HbA1c levels were slightly higher in Iraqis than in Swedes (4.5% vs 4.4%, P=0.038). This difference was explained primarily by clustering in the family history rather than age, obesity, lifestyle or socioeconomic status.
CONCLUSION: The study shows that the greater predisposition to diabetes in Middle Eastern immigrants may be explained by a more extensive family history of the disorder; clinical interventions tailored to Middle Eastern immigrants with such a family history are thus warranted.
Copyright © 2014 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Diabetes onset; Heredity; Hyperglycaemia; Immigrant; Middle East

Mesh:

Substances:

Year:  2014        PMID: 25284578     DOI: 10.1016/j.diabet.2014.08.003

Source DB:  PubMed          Journal:  Diabetes Metab        ISSN: 1262-3636            Impact factor:   6.041


  6 in total

1.  Diabetes mellitus risk among Jordanians in a dental setting: a cross-sectional study.

Authors:  Melanie Fawaz Alazzam; Azmi Mohammad-Ghaleb Darwazeh; Yazan Mansour Hassona; Yousef Saleh Khader
Journal:  Int Dent J       Date:  2020-07-23       Impact factor: 2.607

2.  Simple risk score to screen for prediabetes: A cross-sectional study from the Qatar Biobank cohort.

Authors:  Mostafa Abbas; Raghvendra Mall; Khaoula Errafii; Abdelkader Lattab; Ehsan Ullah; Halima Bensmail; Abdelilah Arredouani
Journal:  J Diabetes Investig       Date:  2020-12-01       Impact factor: 4.232

3.  Family history of diabetes and its relationship with insulin secretion and insulin sensitivity in Iraqi immigrants and native Swedes: a population-based cohort study.

Authors:  Louise Bennet; Paul W Franks; Bengt Zöller; Leif Groop
Journal:  Acta Diabetol       Date:  2017-12-22       Impact factor: 4.280

4.  BMI and waist circumference cut-offs for corresponding levels of insulin sensitivity in a Middle Eastern immigrant versus a native Swedish population - the MEDIM population based study.

Authors:  Louise Bennet; Karin Stenkula; Samuel W Cushman; Kerstin Brismar
Journal:  BMC Public Health       Date:  2016-12-09       Impact factor: 3.295

5.  Which anthropometric measures best indicate type 2 diabetes among Russian, Somali and Kurdish origin migrants in Finland? A cross-sectional study.

Authors:  Natalia Skogberg; Tiina Laatikainen; Annamari Lundqvist; Eero Lilja; Tommi Härkänen; Päivikki Koponen
Journal:  BMJ Open       Date:  2018-05-17       Impact factor: 2.692

6.  The association between plasma proneurotensin and glucose regulation is modified by country of birth.

Authors:  A Fawad; P M Nilsson; J Struck; A Bergmann; O Melander; L Bennet
Journal:  Sci Rep       Date:  2019-09-20       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.